Abstract-Perfluorooctane sulfonic acid (PFOS) accumulates in the liver and blood of exposed organisms. The potential for these surfactant molecules to interfere with hormone/protein interactions in blood is of concern given the importance of these interactions. The PFOS binding to serum proteins was investigated by assessing its ability to displace a variety of steroid hormones from specific binding proteins in the serum of birds and fishes. Perfluorooctane sulfonic acid had only a weak ability to displace estrogen or testosterone from carp serum steroid binding proteins. Displacement of cortisone in avian sera occurred at relatively low PFOS concentrations. Corticosterone displacement potency increased with chain length, and sulfonic acids were more potent than carboxylic acids. The PFOS concentrations estimated to cause these effects were 320 M or greater, equivalent to serum concentrations greater than 160 mg/L. Using mass spectrometry and direct in vitro binding assays, PFOS was demonstrated to bind strongly to bovine serum albumin (BSA) in a 1:1 stoichiometric ratio. It appears that PFOS in serum is in general bound to albumins. Concentrations of PFOS required to saturate albumin would be in excess of 50 to 100 mg/L. Based on current environmental concentrations, it is unlikely that PFOS would cause displacement of hormones from serum proteins in wildlife.
INTRODUCTION
Until recently, the environmental occurrence of organofluorine chemicals has received little attention, mainly because of their relatively low toxicity and difficulties in their chemical analysis. Perfluorinated organic chemicals have a wide variety of applications, such as starting material for polymers, surfactants, and pesticides [1] . Despite their intensive use, little information has been available on their environmental fates and effects. While the first measurements of these chemicals in human serum date from the 1960s [2] , their environmental distribution has only recently been investigated [1] . These studies have demonstrated a wide global distribution of perfluorinated sulfonic chemicals and, to a lesser extent, carboxylic chemicals, such as perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA), in wildlife species. Furthermore, these studies demonstrated that even in remote Arctic areas, small but detectable concentrations of PFOS could be measured in the blood and liver of wildlife [3, 4] . The greatest concentrations of PFOS were found in top predators, such as bald eagles (2.5 g/ml in serum) and mink (3.6 g/g liver) [3, 4] . The fact that this class of chemicals is persistent and widely distributed suggested that the potential risks of the chemicals to wildlife should be investigated.
The environmental behavior of this class of chemicals differs from other known persistent organohalogens. Because of their hydrophylic nature, chemicals such as PFOS do not accumulate in lipids but are found at the greatest concentrations in blood and liver [1, 4, 5] . The physicochemical structure of the PFOS molecule suggests the possibility of interactions of either the sulfonic acid group or the hydrophobic alkyl chain with serum proteins. One of the possible sites of action might be to interact with those serum proteins that are involved in * To whom correspondence may be addressed (jonespa7@msu.edu).
endocrine and immunological functions. It has been proposed that interaction of chemicals with certain serum proteins might disturb normal endocrine function [6] .
Two important groups of proteins involved in normal endocrine function are the sex-hormone binding globulins (SHBGs), which bind estradiol, testosterone, and dihydrotestosterone, and the corticosteroid-binding globulins (CBGs), which bind glucocorticoids and progesterone. To date, most mammals have been found to have both types of proteins [7, 8] . In contrast, other vertebrate classes may have only one of the two protein classes present [8, 9] . Several roles have been attributed to these steroid binding globulins, but in general, their exact function is unknown. At present, their most important known function appears to be to regulate the bioavailability of circulating hormones [10, 11] . According to the free hormone hypothesis, intracellular steroid concentrations are regulated by their free diffusion through membranes [12] , and the role of steroid binding globulins is to maintain steady-state concentrations of free hormones in the outer cell medium. In general, it is accepted that the unbound fraction is the biologically active fraction because it can freely diffuse into tissues during passage of the blood through capillary beds [13] , while the protein-bound steroids are believed to serve as a reservoir for steroid hormones. On the other hand, immunological evidence has suggested that specific hormone binding globulins might have specific functions within cells [7, [14] [15] [16] [17] . Evidence that processes other than those related to delivery of hormones to cells might be regulated or affected by these proteins is suggested by the fact that SHBG or CBG binding increases adenylate cyclase activity and accumulation of cAMP in the cells [18] . Furthermore, steroid binding globulins might influence endocrine metabolism by affecting the clearance rate and half-life of hormones.
Corticosteroids control a wide diversity of physiological, behavioral, and endocrinological processes. They are trans-ported from the tissue where they are synthesized (adrenals) through the blood toward target cells with the aid of CBGs. These proteins regulate the bioavailability and half-life of the hormone and are hypothesized to affect delivery to the specific cellular sites of action [19] . After target cell interaction, another set of corticoid receptors are activated, giving rise to a cascade of signal transduction pathways. Because of the cascade-like nature of these events, relatively small changes (e.g., 10% change in bioavailability) can generate significant changes in the overall metabolism of the organism.
Previous studies have demonstrated the potential of drugs to interact with SHBG and CBG. Prednisolone, a synthetic glucocorticoid at 2,500 nM (the therapeutic dose), caused a 32% decrease in bound cortisol through interaction with CBG [20] . Furthermore, it has been suggested that only half the available binding sites are occupied by cortisol, which accounts for 96% of the binding in humans [10] . This suggests that CBG is mainly occupied with steroid ligands, creating a large reservoir that can be displaced only by ligand with a greater affinity. It has been clearly demonstrated that a small change in bound cortisol leads to a large change in the free hormone concentration [21] . For example, danazol lowers cortisol binding to CBG by 13%, resulting in a 200% increase in free cortisol when given at a pharmacological dose (5 M). This increase in free cortisol ultimately affects the glucocorticoid-sensitive organs, such as pituitary and hypothalamus [22] , and may explain some of the effects on reproduction that are observed.
By its chemical nature, PFOS is a surface-active molecule. The molecule's surfactant nature and highly hydrophobic aliphatic tail region suggest it may have the potential to bind to sites otherwise occupied by steroid hormones or other lipids. If PFOS, through accumulation in the blood, is able to bind to specific proteins, such as SHBGs or CBGs, important endocrine-related phenomena could be affected. Alternatively, if PFOS is rapidly and tightly bound to nonspecific binding sites, it might be rendered unavailable to interact with other biomolecules. In this case, the presence of PFOS in blood plasma may not result in any measurable adverse effects. Previous studies of other environmentally relevant chemicals have shown that certain compounds are able to affect the specific binding of steroids, although with a relatively low potency as compared to native hormones [23, 24] . The present study investigated the potential of perfluorinated fatty acids and sulfonic acids of varying chain length to displace hormones from specific serum binding proteins. The potential of these compounds to displace hormones was evaluated in several systems, including the sex-hormone binding in fish and corticosteroid binding in two species of birds.
MATERIALS AND METHODS
Both 2,4,6,7-3 H-estradiol ( 3 H-E2) and 3 H-corticosterone ( 3 H-C) were obtained from New England Biolabs (Beverly, MA, USA). The 17␤-estradiol (E2) and corticosterone (C) were purchased from Sigma Chemical (St. Louis, MO, USA) and were prepared as stock solutions in ethanol. Perfluorooctane sulfonic acid was obtained from 3M (St. Paul, MN, USA). Based on NMR analysis, the mixture consisted of 68% straightchain PFOS and 17% branched-chain PFOS. The remaining mass of the technical mixture consists largely of metals, including calcium, magnesium, sodium, nickel, and iron, and minor amounts of shorter-chain-length perfluorinated compounds [25] . The composition for the material used was in accord with previous descriptions of technical-grade PFOS [26] . Perfluorooctanoic acid, perfluorobutyric acid (PFBA), perfluorobutane sulfonic acid (PFBS), perfluorohexane sulfonic acid (PFHS), and perfluorodecanoic acid (PFDA) were obtained from Sigma. Chemicals were dissolved in acetone or dimethylsulfoxide (DMSO). For the binding studies, chemicals were diluted to the desired concentrations in TEMG buffer (Pharmacia, Peapack, NJ, USA) (10 mM Tris-HCl, 1 mM ethylenediaminetetraacetic acid, 1 mM 2-mercaptoethanol, 10% glycerol, 0.02% sodium azide, pH 7.5). Unless indicated, all other chemicals were purchased from Sigma.
Serum preparation
Hormone displacement assays were conducted using dextran-coated charcoal (DCC) to separate unbound ligand from protein-bound ligand using previously described methods [27] . Blood samples were taken from male common carp (Cyprinus carpio), male fowl (Gallus domesticus), or bald eagle (Halieetus leucocephalus). Serum was separated by centrifugation after clotting on ice. Endogenous steroids were removed by charcoal stripping. An equal volume of dextran-charcoal-TEMG buffer was added to the serum. The serum was incubated at room temperature for 30 min, and after vortexing, the charcoal/dextran was removed by centrifugation at 3,000 rpm for 10 min at 4ЊC. All serum displacement assays were conducted at a final protein concentration of 0.5 mg/ml. Protein concentrations were determined using the Bradford assay (BioRad, Hercules, CA, USA).
Displacement assays
Diluted serum (200 l) was placed into ice-cold borosilicate glass vials. The 3 H-steroid (final concentration 15 nM) was added to each vial followed by the different concentrations of test chemical. After incubation overnight at 4ЊC, 0.5 ml dextran-charcoal (0.05% wt/vol) dextran (Dextran T-70, Pharmacia, Peapack, NJ, USA), and 0.5% (wt/vol) charcoal (Norit A charcoal, Sigma) in TEMG buffer were added at 4ЊC, and the sample was vortexed at 0ЊC for 1 min and centrifuged at 3,000 g for 6 min (4ЊC). The supernatant was added to 10 ml scintillation fluid (Safetysolve, Research Products International, Mt. Prospect, IL, USA) and counted in a Hewlett-Packard liquid scintillation counter (Avondale, PA, USA). The potency of each chemical to displace the native hormone was expressed relative to the unlabeled native hormone. For this, a 0.1-fold, 1-fold, 10-fold, 100-fold, and 1,000-fold excess of unlabeled steroid, dissolved in TEMG buffer, was added to the initial incubation instead of the test chemical solution. Effect threshold values were calculated as effective concentration values causing a 10% displacement value (EC10) compared to the control treatment based on the dose-response curves and the dilution factor used to bring the serum to the assay concentration of 0.5 mg/ml.
Scatchard analysis
To characterize the mechanism of displacement, Scatchard analysis was performed with increasing toxicant concentrations. Specific binding was plotted against ligand concentration, after which the regression function was fitted using Sigmaplot (Golden, CO, USA). The number of binding sites (R t ) and the dissociation constant (K d ) were calculated.
Statistical methods
Nonlinear regression analysis was used to fit the concentration-response relationships of the different exposures (Sig- 
Direct protein binding assays
A protein standard mixture was obtained from BioRad. This mixture was diluted to contain 0.5 mg/ml of thyroglobulin, bovine gamma globulin, and chicken ovalbumin; 0.25 mg/ml horse myoglobin; and 0.05 mg/ml of vitamin B12. Bovine serum albumin, Fraction IV, was obtained from Sigma.
To assess protein binding, 0.4 ml of protein solution in 2 mM ammonium acetate buffer was placed in a 1.5-ml Eppendorf tube. Five microliters of 0.2 mg/ml PFOS dissolved in 50:50 volume/volume methanol/2 mM ammonium acetate were then added. The mixture was mixed thoroughly but gently and then allowed to stand at room temperature for 30 min. The sample was then split into two 200-l aliquots for determination of total and protein-bound PFOS. To one faction, 20 l of DCC were added, and to the other, 20 l of water were added. The samples were shaken at room temperature for 2 h and then centrifuged at 10,000 g for 20 min. One hundred microliters of the clear supernatant were transferred to a glass autosampler vial for direct high-performance liquid chromatography/mass spectrometry (HPLC/MS) analysis. The HPLC/ MS analysis was conducted by use of a Micromass Platform II mass spectrometer (Micromass, Beverly, MD, USA) interfaced to a Hewlett Packard 1100 series HPLC as previously described [1, 5] . The analytical column was a 150 ϫ 2-mm Betasil octadecylsilyl from (Keystone Scientific, Bellefonte, PA, USA).
Quadrapole-time of flight protein mass spectrometry
The quadrapole-time of flight (Q-TOF) instrument was used to demonstrate the binding of ligands to proteins in their native state. The instrument was configured to directly measure the ability of serum proteins to bind PFOS using a postcolumn mixing technique followed by removal of unbound PFOS in the Q-TOF instrument. The use of the Q-TOF instrument permits the mass analysis of native proteins. In addition, the instrument can be used as a mass filter to permit the separation of protein-bound and free molecules in real time.
A model protein (bovine serum albumin [BSA]) was analyzed in the presence or absence of PFOS. The instrument used was a Micromass Q-TOF (Micromass). The instrument was configured with minimal source vacuum and limited ionization energies to permit the passage of native or intact protein all the way through the instrument to the mass detector. The system vacuum was adjusted to approximately 10 Ϫ4 Torr, and the source temperatures and voltages were decreased to prevent denaturation of the protein before entry into the mass spectrometer.
Protein and ligand solutions were introduced by a syringe pump directly into the instrument's z-spray source. The sample entering the instrument is charged by passage through a metal capillary and is then nebulized by a gas flow. The solvent is desolvated from the charged droplets until the charge density of the protein molecules is sufficient for them to evaporate out of the droplet. Careful manipulation of the temperature and degree of vacuum in the source can allow proteins to pass into the instrument in their native configuration with all tertiary and quaternary protein structures intact.
Determination of binding capacity of serum proteins for PFOS
Determining the binding capacity of serum proteins for PFCs poses several challenges. While it is relatively easy to determine the total binding of PFCs to a serum sample, it was more difficult to determine to which specific protein or proteins the ligands are bound. To perform this determination, it was first necessary to separate the serum proteins and then determine the amount of PFOS bound to each protein in the mixture. Initial experiments using standard liquid chromatography/mass spectrometry to determine the binding of PFOS to serum proteins suggested that PFOS remained bound to protein during chromatographic separation. However, in experiments with the Q-TOF system, PFOS dissociated from protein during chromatography. It was hypothesized either that the PFOS was only weakly bound and dissociated from the target protein during liquid chromatography separation or that the properties of the column material were such that PFOS preferentially bound to the matrix. Under these circumstances, precolumn binding of PFCs to protein was not deemed a viable method to assay serum proteins/PFC complexes. Therefore, the system was configured to separate the native proteins on the basis of their molecular weight using gel filtration chromatography. The effluent from this column, after passage through an ultraviolet detector to monitor protein elution, was combined with a solution of PFOS (5 mg/L in the same buffer), and the mixture was allowed time to mix and form protein:PFOS complexes by passing through a length of tubing before it entered the Q-TOF instrument. The instrument was configured such that PFOS not bound to protein was filtered out of the system by using the first quadrapole segment of the instrument as a mass filter. After passage through the first sector of the instrument, the protein:PFOS complexes were dissociated using a high collision energy (60 V), and free PFOS was detected at the TOF detector. Only PFOS that had initially been bound to protein could reach the TOF detector. The output from this configuration resulted in a protein concentration profile from the HPLCs ultraviolet detector and a PFOS binding profile from the Q-TOF. This latter profile does not directly measure the actual amount of PFOS bound to these proteins in vivo; rather, it measures the ability of these proteins to bind PFOS.
RESULTS

Effects on estradiol binding in carp serum
Only the longer-chain perfluorinated chemicals significantly displaced 3 H-estradiol from binding sites in carp serum (Fig. 1A) . Relative displacement abilities were calculated for the different compounds compared to the native hormone 17-␤ estradiol ( Table 1 ). The displacement ability of these chemicals differed by functional group (carboxylic vs sulfonic acids) and carbon chain length (ranging from 4-10 carbon atoms). Except for the C4 and C6 perfluorinated sulfonic acids, which showed the least displacing activity, most of the chemicals tested had a similar concentration-response function. The EC10 values were estimated on the basis of the dilutions used to obtain the standardized serum protein concentration of 0.5 mg/ml. Since the calculation of EC10 values was not based on a dilution series, as would be required to accurately determine the in vivo EC10, the values determined are presented as estimated EC10s (Table 1 ). The least estimated EC10 value (greatest affinity of binding) was obtained for PFDA (2,500 M), followed by PFOS (3,576 M), perfluorooctanoic acid (4,244 M), and PFBA (4,772 M). An EC10 value could not be calculated for perfluorobutane sulfonate or PFHS because these compounds were essentially inactive at the environmentally relevant concentrations tested (Table 1 ). Even at the greatest concentrations tested (8,000 M), PFOS was unable to displace more than 6% of testosterone bound to carp serum (Fig. 1B) . The number of binding sites (R t ) and the binding constant (K d ) of PFOS to the steroid hormone binding globulin were determined by Scatchard analysis (Fig. 2) . This analysis revealed that the binding dissociation constant for estradiol from carp SHBG, represented by the slope of each curve, was less in the presence of PFOS (Fig. 2B) . The PFOS concentrations of up to 800 M (400 mg/L) did not significantly (p Ͻ 0.05) affect the number of binding sites. At PFOS concentrations Ն200 M (100 mg/L), an increase in the dissociation constant (K d ) was observed that indicates that the binding affinity of the SHBG for the native hormone was significantly less (p Ͻ 0.05). Estrogen and testosterone displacement could not be measured in avian serum, as these species do not have a highaffinity binding protein for these ligands.
Effects on the cortisol binding in chicken and bald eagle serum
The ability of perfluorinated chemicals to displace corticosteroid hormones from the serum of two avian species was measured (Fig. 3) . The displacement caused by both the carboxylic and the sulfonic acid compounds increased with increasing chain length such that the C4 compounds were able to displace corticosterone from protein binding sites only at relatively great concentrations. In addition, the C8 sulfonic acid was more potent than the C8 carboxylic acid in displacing corticosterone. Corticosterone displacement abilities and estimated effect threshold values were calculated relative to cortisol (Table 2 ). Of the compounds tested, the C4 carboxylic PFBS ϭ perfluorobutane sulfonic acid; PFHS ϭ perfluorohexane sulfonic acid; PFOS ϭ perfluorooctane sulfonic acid; PFBA ϭ perfluorobutyric acid; PFOA ϭ perfluorooctanoic acid; PFDA ϭ perfluorodecanoic acid. and sulfonic acid compounds were the least able to displace the native hormone and had the greatest estimated EC10 values. In chickens, concentrations of C4 compounds required to displace the native hormone from the binding protein were approximately 10
Ϫ6
-fold greater than native cortisol. For PFOS, an estimated EC10 of 320 M (160 mg/L) was determined. This value was slightly less than that obtained for PFHS. The relative affinities of PFOS and PFHS were about 10 Ϫ4 -fold less than that of the native hormone. The estimated EC10 values for PFOA was about 2-fold greater than that of PFOS, while the estimated EC10 for the C10 carboxylic perfluorinated compound (PFDA) was about 1.5-fold greater than that of PFOS. The potency of both the C8 and the C10 carboxylic compounds (PFOA and PFDA) were consequently less than that of PFOS but still in the same order of magnitude (10 Ϫ5 ). In order to characterize the binding of PFOS to the corticosteroid binding globulin, Scatchard analysis was performed on the chicken serum binding data. At the least PFOS concentration tested (25 M), no effect was seen on the average number of binding sites per protein molecule (R t ). Greater concentrations caused the loss of the specific binding of cortisol to the globulin. Therefore, it appears that only nonspecific binding was measured at these greater concentrations of PFOS and that a loss of the ligand-specific binding capacity of the globulin occurred.
The effects of different perfluorinated compounds on corticosteroid binding in bald eagle serum were also assessed (Fig.  3B ). The inverse relationship between the compound chain length and the ability to displace corticosteroid that was observed in chicken was less evident in eagle. For both the carboxylic and the sulfonic acid compounds, the chemicals with the least ability to displace cortisol were the C4 compounds. However, the remaining C6 to C8 and C8 to C10 compounds had similar potencies relative to the displacement of cortisol. Calculated effect threshold values and relative affinities to the native hormone (Table 2) showed that the 4-carbon carboxylic and sulfonic acid had the greatest estimated EC10 values, although for eagle the EC10 values were approximately 5.2-to 2.9-fold less than for the chicken for PFBS and PFBA, respectively. The displacement efficiencies of PFBS and PFBA were 10 Ϫ5 -fold less than that of the native hormone. For PFOS, the estimated EC10 value obtained in eagle plasma was greater than (516 M, equivalent to 258 mg/L) but not statistically different from that obtained for chicken, while the other chemicals had estimated EC10 values comparable to that of PFOS. As a result, the abilities of the different C6 and C10 compounds to displace hormones in eagle were comparable to those measured in chicken.
Direct protein binding studies
In direct protein binding studies, PFOS was found to bind to specific proteins in serum and was not removed from the aqueous assay system by stripping with dextran-coated charcoal (DCC). The BSA prevented the removal of PFOS from aqueous solution in a concentration dependent manner (Fig.  4) . At BSA concentrations of 1 mg/ml and greater, essentially all the PFOS in the mixture (2.35 mg/L) was bound to the protein and could not be removed by treatment with DCC. At BSA concentrations less than 1 mg/ml, an increasing amount of PFOS was removed from the aqueous solution by DCC stripping.
To determine whether the binding activity was specific to BSA, a solution containing a mixture of proteins and a sample of carp serum were analyzed (Fig. 4) . The binding profile of carp serum closely matched that of BSA. This was not surprising since serum albumin is one of the major proteins present in the serum of all vertebrates. In contrast, the binding profile of the protein mixture was clearly different from that observed with BSA or fish serum samples. The protein mixture was prepared as a gel filtration standard, and the proteins are representative of normal aqueous soluble proteins. As well as having a different binding profile, this mixture also had a lower total binding capacity, with the saturation of the protein (all PFOS bound) not being approached until the greatest protein concentration, 16.9 mg/ml. In contrast, the BSA and carp curves were similar in terms of the binding curve but different in efficacy in that the carp sample reached saturation at 9.8 mg/ml.
The protein standard and carp serum are both complex protein mixtures of proteins of diverse molecular weights (Ͻ1,000 to Ͼ1,000,000 M r ). Therefore, it is not possible to calculate a molar protein concentration or a ratio of PFOS bound per protein molecule. However, saturation of the carp serum occurred at approximately a 10-fold greater protein concentration than was observed with BSA (9.8 vs 0.75 mg/ml). Since albumin makes up from 10 to 20% of total serum protein in fish [28] and assuming that the majority of PFOS binding was to albumin, a 10-fold difference in the PFOS/protein saturation concentration would be expected. Since this magnitude of difference between the concentrations at which the protein binding sites become saturated with PFOS was observed, it can be assumed that in carp serum, the majority of the PFOS is bound to albumin.
From these results, we hypothesize that albumin is the major binding site for PFOS in serum. While data are scarce for the concentration of albumin in fish serum, approximately 10 to 20 mg/ml have been measured in freshwater eels, giving an approximate molar albumin concentration of 0.1 to 0.2 M [28] . Thus, based on the stoichiometric data presented here, it can be assumed that it would require one molecule of PFOS bound per molecule of albumin then an equivalent PFOS concentration (0.1-0.2 M, equivalent to 50-100 ppm [mg/L]) would be required to saturate the albumin in serum with PFOS. Therefore, PFOS will not be free to interact with other proteins until the albumin saturation point is exceeded at PFOS concentrations of 50 to 100 mg/L. Above these concentrations, PFOS would be available to associate with other serum proteins or blood components.
Determination of PFOS binding capacity by Q-TOF
Initial experiments were conducted in the presence of 10 mM ammonium acetate buffer at pH 7.6. When the instrument was configured with a low collision energy to allow passage of the intact protein:PFOS complex through to the detector, no free PFOS (m/z 499) was detected (Fig. 5, top panel) . This experiment demonstrated the presence of the multiple charged forms of the protein:PFOS complex that result from the electrospray ionization process. When the instrument was configured to denature the complex by using a greater collision voltage in the ion path between the two segments of the instrument, PFOS was detected (Fig. 5, bottom panel) . In the later experiment, the absence of any native BSA was noted along with an increase in the presence of denatured protein. The apparent lack of mass balance between the native and denatured BSA could be attributable to actual destruction of the polypeptide and smearing of the resulting multiply charged protein fragments.
During the initial studies, it was observed that sensitivity and reproducibility of results could vary from week to week. Reasons for this variability are still being investigated. One source of this variability was due to the buffering system used to introduce the protein solution into the instrument. Initial experiments were conducted using ammonium acetate buffer. However, it was noted that on occasion, this buffer significantly reduced sensitivity of the analysis, so a comparison was carried out between this buffer and pure water (Fig. 6 ). These results demonstrate that under different buffer conditions, the ionizability of BSA varies, and it is probable that this also indicates alterations in the protein structure that result in the exposure of different ionizable groups. Therefore, the question arises as to which buffer system would provide the most physiologically relevant data. The presence of different ionic species in these experiments greatly alters the ionizability of the protein molecules, but it is also probable that these ionic species produce minor alterations in the tertiary structure of the protein. Indeed, such minor structural alterations are necessary for many protein functions, such as ligand binding. Thus, the most appropriate buffer system for serum proteins would be the protein and ion mixture that would approximate the conditions these proteins would be exposed to in vivo. However, the presence of these ionic species can also have an adverse effect on the performance of the Q-TOF instrument. While no ideal buffer is available, the use of a range of different buffers allows buffer-specific as opposed to ligand-specific effects to be accounted for in the assay.
The multiple charged peaks detected in the Q-TOF procedure can be deconvoluted to yield an accurate mass estimate for the native protein. This mathematical algorithm takes data from the profile of multiple peaks of multiply charged ions in the mass chromatograph and determines the actual molecular weight of the molecule. This procedure was conducted using the MAXENT utility (Micromass) supplied with the Q-TOF instrument. Using this procedure in two replicate experiments where the mass of BSA was measured with or without PFOS, it was determined that the M r of BSA alone was 67,350 (n ϭ 2, standard deviation ϭ 106) while in the presence of PFOS, the M r increased to 68,075 (n ϭ 2, standard deviation ϭ 35), a difference of 725 mass units. These values can be compared to the theoretical M r of albumin of 66,780. The difference of 570 mass units from the theoretical M r is due to the fact that the measured M r is an estimate based on mass/charge ratio and is sensitive to the charge on the molecule at the time of determination. The isoelectric pH of BSA is approximately 4.9, and so at the neutral conditions used in for measurement, additional charge would be present on the molecule. In addition, while the BSA used was defatted, the presence of some residual fatty acids or other ligands or of other ions attached to specific amino acids could result in the relatively minor variation (Ͻ1%) from the theoretical molecular mass. The difference of 750 mass units suggests the binding of 1.5 PFOS molecules per BSA molecule, which is not stoichiometrically possible. Therefore, it would be expected that either one or two PFOS molecules were bound per BSA molecule. When combined with the results of the direct binding studies that also suggest less than one PFOS molecule per BSA molecule, it can be concluded that one PFOS is bound per BSA molecule. The deviation from this theoretical binding value observed in the results of the QTOF analysis could have been due to several factors. The PFOS may bind to BSA in a charged state, thus altering the charge as well as the mass of the molecule that would result in an apparent mass unit change other than 1.0. Alternatively, the binding of PFOS to BSA may result in conformational alterations in the BSA molecule that lead to an alteration in the charge state of the protein. In the direct binding assays, it is possible that differential binding of the straight-(70%) and branched-chain (17%) compounds occurs. However, the direct MS binding analysis did not differentiate between the two forms of PFOS. The consequences of differential binding of straight-chain and branch-chain forms of PFOS to albumin require further investigation.
The molecular-weight-shift determination was repeated with a range of PFOS concentrations to determine whether additional binding sites could be identified. Between concentrations of 0.1 and 10 mg/L PFOS, a steady shift in the molecular mass of the albumin peak was detected. This shift corresponded to an M r increase from just less than 67,500 to approximately 68,100, which corresponds to the binding of one PFOS molecule. However, at a concentration of 20 mg/ L, the molecular mass profile was considerably different (results not shown). While the molecular weight for the BSA peak had increased and evidence existed of still higher-molecular-weight forms appearing (ϳ75,000 M r ), the intensity of all signals at this PFOS concentration were considerably decreased, indicating a loss of the native form of BSA. This loss of signal is indicative of significant denaturation of BSA such that PFOS binding was no longer possible. 
Determination of binding capacity of serum proteins for PFOS
Experiments were conducted using the Q-TOF system to assess the potential of BSA and carp serum proteins to bind PFOS (Figs. 7 and 8 ). While it was strongly indicated that PFOS was bound to a protein of similar molecular weight to that of albumin, the signal-to-noise ratio was poor in this experiment. This was due, in part, to the fact that the carp serum sample had been diluted to a concentration of 2 mg protein/ ml, which was approximately fourfold greater than the previous BSA experiments. In addition, the system was not yet optimized with respect to effluent flow parameters or for instrument conditions such that the signal-to-noise ratio was relatively low, even when evaluated with a 20 mg/ml BSA solution.
Risk estimation
To evaluate the possibility of adverse effects due to current environmental concentrations of PFOS, estimated EC50 concentrations were compared to recently measured concentrations of PFOS in fish and birds [1, [3] [4] [5] . While the threshold concentrations were derived in serum, the tissue measurements represent a range of tissues. The PFOS concentrations in muscle and liver tissue of fishes were below the threshold effect level derived for steroid displacement in carp serum (1,788 mg/kg) (Fig. 9 ). This provides a safety margin of approximately 4,700 when the threshold value is compared to the greatest measured environmental concentration, 0.38 mg/kg, measured in lake whitefish eggs from the Great Lakes (North America) region [1, [3] [4] [5] . Similarly, all measured environmental concentrations of PFOS in bird tissues were less than the estimated threshold concentrations for effect (Fig. 10) . When the most sensitive threshold value for cortisol displacement in birds (160 mg/L) is compared to the greatest measured environmental concentration (2.57 mg/L, bald eagle plasma from the midwestern United States), a safety factor of 62 is derived. Since species-specific data and a threshold for effect is available for the bald eagle, the species-specific safety factor is 100. Thus, based on the endpoints assessed in our studies, it seems that current environmental concentrations of PFOS are two to three orders of magnitude below concentrations that would be expected to cause the effects.
DISCUSSION
While the Q-TOF approach offers many advantages in studying protein binding, some limitations exist. The buffering system used is critical, as it affects both the protein structure and the instrument performance. Unfortunately, from the results obtained in our studies, these criteria appear to be diametrically opposed. The more physiologically relevant the buffer system becomes, the more instrument performance was degraded. In addition, the MS instrument performs best at high temperatures and low pressures, conditions that result in rapid denaturation of protein molecules. To obtain transmission of the intact proteins through the instrument required decreased temperatures and pressures as close to atmospheric as possible without tripping the instrument. Therefore, these experiments were performed on a knife edge and were difficult to repeat, but the results were reproducible when repetition was achieved. Further work is needed to determine the most relevant and reproducible buffer system to satisfy both criteria.
The Q-TOF experiments support the previous observations of a binding stoichiometry of approximately one PFOS molecule per BSA molecule. This stoichiometry was demonstrated both by direct binding studies in a BSA solution and by Q-TOF MS analysis of native BSA. Therefore, in order to saturate carp serum, it would require serum PFOS concentrations of 50 to 100 mg/L, considerably greater than concentrations observed in wildlife to date. It should also be noted that effects of PFOS on the binding of steroids to serum binding proteins were also not seen until the PFOS concentrations were greater than 100 mg/L. Therefore, it seems that a requirement exists for the saturation of all albumin binding sites before free PFOS can affect the binding of steroid hormones to their serum carrier proteins.
Currently, in studies evaluating the endocrine-disrupting potencies of chemicals, increasing attention is being paid to nonreceptor-mediated processes. One possible mechanism is the interaction of toxicants with serum steroid binding proteins. Previous research has demonstrated that certain environmental contaminants, such as bisphenol A, octylphenol, and nonylphenol, are weak human SHBG ligands able to displace E2 from the SHBG, albeit with a relatively low potency [23] . For instance, at concentrations of 10 to 100 M, these contaminants were able to increase the fraction of SHBG-unbound estradiol [24] . Because PFOS has been found to be selectively retained in the blood of wildlife and humans in both laboratory and field studies, the potential for such displacement was investigated.
The PFOS did not significantly affect the average number of binding sites on the carp SHBG at concentrations of up to 800 M (400 mg/L). Therefore, the displacement of estradiol was caused by a decrease in binding affinity of the protein for the native hormone. This suggests that in this situation, these chemicals exert their affects through a nonspecific interaction with the protein rather than through a specific interaction with the ligand binding site. Since the greater proportion of the binding of the native ligand to the protein occurs via hydrophobic interactions, it would appear that the amphipathic nature of the perfluorinated compounds causes conformational alterations in the ligand binding site, and so the effects on binding would seem to be indirect rather than due to displacement by binding of PFOS to specific hormone binding sites.
The ability of PFOS to displace 17␤-estradiol in avian species was low compared to the native hormone. That is, on a molar basis, the ability of PFOS to displace 17␤-estradiol was 10 Ϫ3 -to 10 Ϫ5 -fold less than that measured with 17␤-estradiol. These data suggest that compounds, including PFOS, are able to displace native hormones from their binding globulin, but only at relatively great concentrations. Whether or not these effects would occur in vivo would depend on the internal exposure and sensitivity of an organism to alterations in its steroid homeostasis under natural conditions. As a result, it is unlikely that any effects would be observed at current concentrations of PFOS observed in the environment [5] .
In order to evaluate the environmental hazard associated with displacement of steroid hormones by PFOS, estimated EC10 thresholds were compared with concentrations measured in blood plasma or fish [1] . As a conservative/worst-case scenario, the greatest PFOS concentration measured in fish was used as the predicted or estimated environmental concentration. Based on this assumption, the hazard associated with PFOS concentrations in the environment and its potential effects on the SHBG in fish were low. Based on available information, the effect threshold was more than 10 Ϫ2 -fold less than the maximum exposure concentrations. Thus, it can be concluded that under environmentally relevant conditions, no effects on hormone binding in blood of fish would be expected. Said another way, the minimum safety factor between current concentrations and the threshold for displacement is at least 100-fold. Furthermore, since this ratio is with the threshold value, even greater concentrations would be necessary to reach an effect level.
To evaluate the environmental hazard of PFOS relative to its ability to displace corticosterone from CBG in birds, the effect threshold values (EC10s) for chicken and eagle were compared with the environmental data reported [1] . Based on these data and on an environmental concentration of PFOS in blood of top-predatory birds (greatest PFOS concentration measured in eagle blood, 2.68 g/ml) and an in vitro-based effect threshold (EC10) for PFOS (257 g/ml), the threshold for effect is 100-fold greater than the maximum concentrations observed in blood of birds collected from the wild. Based on these relationships, the hazard quotient would be 0.01 with a margin of safety of 96.0. Therefore, current concentrations of PFOS would not be expected to cause measurable effects on the hormone status of birds.
These studies indicate that in in vitro studies, PFOS and related compounds are able to alter the binding of steroid hormones to specific serum binding proteins. However, these effects occur only at relatively great concentrations of the perfluorinated chemicals. The relatively great concentrations needed to express these effects could be due to two phenomena: The chemicals bind with high affinity to albumin and so are not available to other sites of action until the pool of available binding sites on albumin are occupied, and the effects are relatively nonspecific alterations in hydrophobic interactions that maintain the protein secondary and tertiary structure rather than the direct competitive binding at the ligand binding site.
The binding of PFOS to albumin has the potential to displace the native ligands from this important transport protein.
While albumin is principally involved in the transport of fatty acids, it also functions in the binding and transport of a wide range of endogenous and exogenous metabolites, drugs, and organic compounds [29] . Human serum albumin has at least five and possibly eight fatty acid binding sites, of which three are classified as high affinity [29, 30] . Since our experiments indicate that one molecule of PFOS binds per albumin molecule, it seems unlikely that PFOS competes for all these fatty acid binding sites. However, human serum albumin binds the inhaled anesthetics propofol (two molecules) and halothane (three molecules) as well as other ligands in some of the fatty acid binding sites [31, 32] . The topography and binding characteristics of all the fatty acid binding sites have been examined [30] . In the high-affinity sites, electrostatic interactions with the polar fatty acid head as well as hydrophobic interactions with the fatty acid tail stabilize the ligand binding. Interestingly, these studies failed to demonstrate the binding of fatty acids shorter than C10 to human serum albumin; a similar observation has been made for the binding of such fatty acids to rat mammary gland fatty acid binding protein (FABP), a tissue that is rich in this and other short-/mediumchain fatty acids [33, 34] . These studies demonstrate that fatty acids less than C10 are sufficiently soluble that their binding to fatty acid binding proteins is unnecessary. Given the relatively great solubility of PFOS, it may also be the case that it does not interact significantly with the fatty acid binding sites, a hypothesis supported by the previously suggested 1:1 binding stoichiometry. As discussed previously, albumin also binds a variety of xenobiotics at two of the fatty acid binding sites [30] . Of these two sites, one (drug site 1) seems to preferentially bind short-and medium-chain fatty acids, while the other (drug site 2) preferentially binds long-chain fatty acids.
From the present study, we would hypothesize that PFOS binds to drug site 1. While extracellular fatty acids are effectively bound by albumins, intracellular fatty acid binding and transport are carried out by a group of low-molecular-weight proteins called the fatty acid binding proteins. These proteins occur in all tissues and are thought to regulate the metabolic fate of fatty acids. Despite possessing the required hydrophobic and hydrophilic regions to bind to these proteins, PFOS has been shown to bind only weakly to liver FABP [35] . While PFOS may compete for binding sites with some low-affinity ligands, such as cholesterol, oleic acid had an affinity almost 500 times greater than PFOS for the liver FABP. Given the much greater relative affinity of oleic acid and the presence of other natural ligands for the FABPs, it seems unlikely that the binding of PFOS to these proteins represents a significant mode of biological action. It would also seem unlikely that FABP would represent a significant pool of intracellular binding of PFOS. This leaves unexplained the site of or reason for the significant accumulation of PFOS seen in liver [5] . One possible explanation for the accumulation of PFOS in liver could be enterohepatic recirculation due to excretion of PFOS in bile followed by resorption from the gut [36] .
Other studies have suggested that mammals in particular contain a saturable pool of PFOS binding sites that protect the organism from adverse effects [25, 37] . Once saturated, the organism could be exposed to concentrations of free PFOS that cause adverse toxic effects. Evidence for the saturation of this binding pool is the very steep dose-response relationship observed in several mammalian exposure studies. Until a specific body burden, measured as total mass of chemical accumulated, is reached, mammals are tolerant to PFOS exposure. However, once the critical dose is exceeded, mortality increases very rapidly. Based on the current studies, it seems most likely that the binding pool is serum albumin, a fact that has several implications for the assessment of possible risks of perfluorinated compounds to wildlife. First, organisms that do not have large quantities of albumin or whose albumin does not bind these chemicals would be expected to be more vulnerable to the toxic effects of perfluorinated chemicals. However, a second implication of albumin binding would be that species lacking albumins would presumably not accumulate the relatively great concentrations observed in those species that do possess albumins. Third, it would seem more appropriate to use total accumulated dose of contaminants as an exposure metric rather than the more frequently used exposure metrics, such as exposure concentrations. Finally, the ability of these chemicals to bind to albumin suggests the potential for transfer of the chemicals to developing mammalian young by lactation. This behavior mimics that of the classic persistent organics that transfer via fat in milk but has a completely different mechanism of transfer. While albumin is known to be a major milk protein in many species, the implications of chemical binding to milk albumin and subsequent transfer to the young require investigation. Therefore, the binding of PFOS to protein can be looked at in two lights: Binding to or effects on specific proteins may be a negative impact, while binding to albumin may be seen as a positive or ameliorative effect. We would also suggest that chemicals of this class that do not bind to albumin have a greater potential to cause adverse effects at other sites of action.
